NEFM and cholangiocarcinoma: By contrast, NEFM expression was comparable between tumor and normal tissues in THCA (thyroid carcinoma), KIRP (kidney renal papillary cell carcinoma), CHOL (cholangiocarcinoma), ESCA (esophageal adenocarcinoma), LIHC (liver hepatocellular carcinoma), LUSC (lung squamous carcinoma), THCA (thyroid carcinoma) and LIHC (liver hepatocellular carcinoma) (Fig. 1b).